Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    spiriva | cystic fibrosis
Show Display Options
Rank Status Study
1 Completed Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Interventions: Drug: Tiotropium bromide low;   Drug: Tiotropium bromide medium;   Drug: Tiotropium bromide high;   Drug: Placebo
2 Completed
Has Results
Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Placebo Respimat;   Drug: Tiotropium bromide 5 mcg;   Drug: tiotropium bromide-low dose-2.5mcg
3 Completed
Has Results
Tiotropium Bromide in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: tiotropium Respimat® inhaler;   Drug: Placebo Respimat® inhaler

Indicates status has not been verified in more than two years